EUVIMEDEUVIMED entdecken
Crossref

Multimodal Japanese-style acupuncture and moxibustion for taxane-related chemotherapy-induced peripheral neuropathy in breast cancer survivors

Hiroto Ishiki, Eriko Satomi, Hiromichi Matsuoka, Sayaka Arakawa, Naruaki Kawasaki, Yoko Horiguchi, Asuka Takahashi, Tatsuya Takagi, Shota Kobayashi, Shunsuke Oyamada, Keisuke Ariyoshi, Kota Kihara und 3 weitere

Supportive Care in Cancer · 2026-10 · 34 (10)

DOI: 10.1007/s00520-026-11237-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 22.09.2026. Verfasst von Hiroto Ishiki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan. hishiki@ncc.go.jp. Hauptthemen laut MEDLINE: Acupuncture Therapy, Antineoplastic Agents, Breast Neoplasms, Moxibustion. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Taxane-related chemotherapy-induced peripheral neuropathy (CIPN) is highly prevalent among breast cancer survivors and significantly impairs quality of life, yet established treatments are lacking. This study investigated the preliminary efficacy and safety of multimodal Japanese-style acupuncture and moxibustion (MJAM)-a program combining filiform needle acupuncture, non-insertive needle (Teishin) therapy, motion-style acupuncture, indirect moxibustion, hot pack application, and self-care instruction-for taxane-related CIPN. METHODS: In this single-center, single-arm study, we enrolled breast cancer survivors who had completed curative treatment for stage I-III breast cancer at least 3 months previously and who had moderate-to-severe taxane-related CIPN pain (BPI item 5 score of 4 or greater) at the time of enrollment. Participants received 12 weekly sessions of a standardized MJAM program. The primary endpoint was the change in Brief Pain Inventory (BPI) item 5 (average pain) from baseline to week 16. RESULTS: Between October 2022 and April 2024, 30 women (median age 58.0 years) were enrolled. Median time since chemotherapy completion was 2.47 years. Mean baseline BPI item 5 score was 5.3 (SD 1.7). Twenty-eight participants (93.3%) completed the treatment. Nine participants (30.0%) experienced mild (grade 1) adverse events. BPI item 5 scores significantly decreased over time. Changes from baseline were -0.1 (95%CI, -0.6 to 0.3; p = 0.56) at week 4, -0.7 (95%CI, -1.2 to -0.2; p = 0.008) at week 8, -1.1 (95%CI, -1.7 to -0.6; p = 0.0003) at week 12, and -1.2 (90%CI, -1.7 to -0.8; p < 0.0001) at week 16. CONCLUSIONS: MJAM was safe, feasible, and associated with a reduction in pain in breast cancer survivors with persistent taxane-related CIPN. A confirmatory randomized clinical trial is warranted. TRIAL REGISTRATION: UMIN-CTR UMIN000048478.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acupuncture TherapyAntineoplastic AgentsBreast NeoplasmsMoxibustionPeripheral Nervous System DiseasesTaxoidsAdultAgedFemaleHumansMiddle AgedCancer SurvivorsCombined Modality TherapyJapanPain MeasurementQuality of LifeBridged-Ring Compounds

Stichwörter der Autor:innen

AcupunctureBreast cancerChemotherapy-induced peripheral neuropathyMoxibustionSurvivorship

Substanzen

Antineoplastic AgentstaxaneTaxoidsBridged-Ring Compounds

Autor:innen und Institutionen

  • Department of Palliative Medicine, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan. hishiki@ncc.go.jp.
  • Department of Palliative Medicine, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan.
  • Department of Psycho-oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Department of Biostatistics, JORTC Data Center, Tokyo, Japan.
  • Department of Data Management, JORTC Data Center, Tokyo, Japan.

Zitieren

APA

Ishiki, H., Satomi, E., Matsuoka, H., Arakawa, S., Kawasaki, N., Horiguchi, Y., Takahashi, A., Takagi, T., Kobayashi, S., Oyamada, S., Ariyoshi, K., Kihara, K., Suto, A., Murata, T., & Takayama, S. (2026). Multimodal Japanese-style acupuncture and moxibustion for taxane-related chemotherapy-induced peripheral neuropathy in breast cancer survivors. Supportive Care in Cancer, 34(10). https://doi.org/10.1007/s00520-026-11237-1

Vancouver

Ishiki H, Satomi E, Matsuoka H, Arakawa S, Kawasaki N, Horiguchi Y, et al. Multimodal Japanese-style acupuncture and moxibustion for taxane-related chemotherapy-induced peripheral neuropathy in breast cancer survivors. Supportive Care in Cancer. 2026;34(10). doi:10.1007/s00520-026-11237-1

BibTeX
@article{Ishiki2026,
  author = {Ishiki, Hiroto and Satomi, Eriko and Matsuoka, Hiromichi and Arakawa, Sayaka and Kawasaki, Naruaki and Horiguchi, Yoko and Takahashi, Asuka and Takagi, Tatsuya and Kobayashi, Shota and Oyamada, Shunsuke and Ariyoshi, Keisuke and Kihara, Kota and Suto, Akihiko and Murata, Takeshi and Takayama, Shin},
  title = {Multimodal Japanese-style acupuncture and moxibustion for taxane-related chemotherapy-induced peripheral neuropathy in breast cancer survivors},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {10},
  doi = {10.1007/s00520-026-11237-1}
}
Kostenlos starten →